Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Capital Reinvestment Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥109.83 Million) in capital expenditures (CN¥6.99 Million). Check tangible net worth ratio of Shanghai Shenqi Pharmaceutical Investmen to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Capital Reinvestment Ratio (1998–2025)
This chart tracks Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see Shanghai Shenqi Pharmaceutical Investmen (600613) cash flow conversion.
Annual Capital Reinvestment Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. See 600613 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | CN¥124.47 Million | CN¥33.22 Million | ▲ +52.4% |
| 2024 | 0.18x | CN¥207.79 Million | CN¥36.39 Million | ▲ +54.0% |
| 2023 | 0.11x | CN¥215.59 Million | CN¥24.51 Million | ▲ +36.2% |
| 2022 | 0.08x | CN¥319.23 Million | CN¥26.64 Million | ▼ -82.1% |
| 2021 | 0.47x | CN¥184.26 Million | CN¥85.96 Million | ▼ -52.0% |
| 2020 | 0.97x | CN¥99.10 Million | CN¥96.31 Million | ▲ +62.0% |
| 2019 | 0.60x | CN¥128.28 Million | CN¥76.96 Million | ▼ -19.2% |
| 2018 | 0.74x | CN¥148.53 Million | CN¥110.25 Million | ▼ -54.3% |
| 2017 | 1.62x | CN¥66.99 Million | CN¥108.84 Million | ▼ -97.8% |
| 2016 | 75.16x | CN¥570.41K | CN¥42.87 Million | ▲ +3320.6% |
| 2015 | 2.20x | CN¥30.12 Million | CN¥66.18 Million | ▲ +195.5% |
| 2013 | 0.74x | CN¥74.75 Million | CN¥55.58 Million | ▲ +4176.6% |
| 2010 | 0.02x | CN¥33.04 Million | CN¥574.38K | ▼ -85.3% |
| 2009 | 0.12x | CN¥7.69 Million | CN¥907.90K | ▲ +741.2% |
| 2008 | 0.01x | CN¥25.26 Million | CN¥354.57K | ▼ -75.2% |
| 2007 | 0.06x | CN¥16.01 Million | CN¥906.84K | ▼ -47.0% |
| 2005 | 0.11x | CN¥32.72 Million | CN¥3.50 Million | ▼ -91.6% |
| 2004 | 1.27x | CN¥4.96 Million | CN¥6.29 Million | ▲ +808.9% |
| 2003 | 0.14x | CN¥4.52 Million | CN¥629.83K | ▼ -31.0% |
| 2002 | 0.20x | CN¥16.02 Million | CN¥3.24 Million | ▼ -53.8% |
| 2000 | 0.44x | CN¥26.85 Million | CN¥11.76 Million | ▲ +2282.2% |
| 1998 | 0.02x | CN¥72.67 Million | CN¥1.34 Million | — |